Business · 15/10/20261 min read
XtalPi Nominates Its First siRNA Preclinical Candidate for IgA Nephropathy Nine Months After Program Initiation
Summary
XtalPi has nominated its first siRNA preclinical candidate for IgA Nephropathy, nine months after program initiation, with preclinical data demonstrating subnanomolar silencing potency.
Original source language: PR NewswireOpen original release →